Comparison
5p Partial Monosomy Syndrome C0010314 vs 2 Oxoadipic Aciduria C4011938
Clinical comparison between 5P Partial Monosomy Syndrome and 2 Oxoadipic Aciduria for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
2 Oxoadipic Aciduria C4011938
A metabolic condition affecting the breakdown of lysine and tryptophan. Acidic byproducts accumulate and may cause health issues. Managed with specialized diet and monitoring.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
2 Oxoadipic Aciduria C4011938
0-18
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
2 Oxoadipic Aciduria C4011938
moderate
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
2 Oxoadipic Aciduria C4011938
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
2 Oxoadipic Aciduria C4011938
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
2 Oxoadipic Aciduria C4011938
metabolic
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
2 Oxoadipic Aciduria C4011938
metabolic
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 2-oxoadipic-aciduria-C4011938 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 2 Oxoadipic Aciduria C4011938 | Discriminating power |
|---|---|---|---|
| Newborn cry | High-pitched, cat-like cry is characteristic but not universal. | No characteristic cry is established. | High |
| Development | Developmental delay and intellectual disability are typical. | Neurologic effects may occur, but severity is variable and not fully established. | Moderate |
| Metabolic signs | Not primarily a metabolic accumulation disorder. | Acidic lysine–tryptophan byproducts may accumulate. | High |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Congenital features from birth
Chromosomal deletion fits congenital onset and dysmorphic or developmental findings.
High
Characteristic cry
A high-pitched cry supports consideration of 5p deletion.
Moderate
No metabolic accumulation pattern
Absence of relevant organic-acid abnormalities favors a chromosomal rather than metabolic explanation.
Moderate
Choose 2 Oxoadipic Aciduria C4011938 when
Abnormal organic acids
Lysine–tryptophan metabolites suggest 2-oxoadipic aciduria, pending confirmation.
High
Later childhood presentation
Onset may extend beyond the newborn period, unlike typical congenital recognition.
Moderate
Diet-responsive metabolic concern
Specialized diet and monitoring are described management approaches.
Low
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 2 Oxoadipic Aciduria C4011938 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | Deletion involving chromosome 5p may be found. | No 5p deletion is expected from this diagnosis. | Confirms a chromosomal cause when clinically correlated. |
| Urine organic acids | No specific organic-acid pattern is established. | 2-oxoadipic and related metabolites may be elevated. | An abnormal result requires clinician and laboratory interpretation. |
| Genetic metabolic testing | Not the primary confirmatory test. | Gene testing may support the biochemical finding. | Use to distinguish biochemical abnormality from confirmed disorder. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- Usually lifelong developmental disability; survival varies and is not quantified here.
- Factors
- Deletion extent, associated anomalies, and support services.
2 Oxoadipic Aciduria C4011938
- Outcome
- Often described as moderate, but outcomes vary and are incompletely established.
- Factors
- Biochemical severity, neurologic involvement, diet, and monitoring.
Time frame: Lifelong for both; review regularly.
Clinician interpretation should guide prognosis.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Often substantial developmental and intellectual impairment. Possible neurologic issues; range is uncertain. Individual assessment is required. |
| Feeding or growth | Feeding difficulty and poor growth may occur. Dietary restriction and monitoring may affect nutrition. Exact frequency is not established here. |
| Acute metabolic decompensation | Not a typical feature. Metabolic stress could pose concern, but risk is not quantified. Seek urgent care for concerning illness. |
Patient education highlights
- HighDiagnosis confirmation
Ask which test confirmed the condition and how results were interpreted.
- HighDevelopmental support
Early therapy and educational planning may help either condition.
- MediumMetabolic precautions
For aciduria, follow the specialist’s diet and illness-monitoring plan.